IMNM Jean Jacques Bienaime bought Immunome Inc. shares — SEC Form 4BUYImmunome Inc.

Jean Jacques Bienaime, Director at Immunome Inc. (IMNM), bought 7,000 shares at $13.94 ($98K) on 2024-08-16, disclosed to the SEC on 2024-08-19.

SEC EDGAR Filing

0001415889-24-021659

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Notable63/100

Something here stands out, but not much.

Major Holdings Increase (>50%)Opportunistic BuyFirst-Time BuyerLargest Purchase Ever

Trade Context

•Increased holdings by 73%
•Largest purchase ever, out of 8
•Stock down -48% in previous 6 months
•Mid-Cap ($2B-$10B market cap)

Filing Info

Filed2024-08-19

Traded2024-08-16

Accession0001415889-24-021659

SourceSEC EDGAR (Historical)

Insider

NameJean Jacques Bienaime

TitleDirector

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
KROS	BUY	2026-08-19	$10K	—	Filing →
ASND	BUY	2026-08-18	$493K	—

Get an email when an insider at IMNM files

Free account. Follow IMNM and up to 10 more companies.

Follow IMNM for free

IMNM Jean Jacques Bienaime bought Immunome Inc. shares — SEC Form 4BUYImmunome Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes